ETCGX (ETCGX) Stock Price & Analysis
ETCGX (ETCGX) rose 0.17% to USD 51.7 as of September 9, 2026 at 03:49 UTC, according to Nexqual real-time market data.
ETCGX last closed at USD 51.61; the session ranged USD 51.7–51.7 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 40.73–55.79 (NAS). Source: Nexqual, September 9, 2026 at 03:49 UTC.
Key Statistics (as of September 9, 2026 at 03:49 UTC)
| Price | USD 51.7 |
|---|---|
| Change | ▲ 0.17% (up) |
| Previous Close | USD 51.61 |
| Open | USD 51.7 |
| Day Range | USD 51.7 – 51.7 |
| 52-Week Range | USD 40.73 – 55.79 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (ETCGX)
Nexqual's technical model rates ETCGX "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 03:49 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 45.29 (neutral) |
| vs SMA50 | Below (USD 52.74) |
| MACD | -0.32 (negative) |
Financial Health Score (ETCGX)
Nexqual rates ETCGX's overall financial health "Mixed" across five dimensions, as of September 9, 2026 at 03:49 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ETCHX | Eventide Healthcare & Life Scie | USD 51.96 | ▲ 0.33% |
| ETAGX | Eventide Gilead Fund Class A | USD 61.61 | ▲ 0.87% |
| ETILX | Eventide Gilead Fund Institutio | USD 64.94 | ▲ 0.85% |
| ETGLX | Eventide Gilead Fund | USD 62.2 | ▲ 0.86% |
| ETAHX | Eventide Healthcare & Life Scie | USD 57.95 | ▲ 0.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 03:49 UTC. This page is informational and not investment advice.